Multiple Site Testing Evaluation - Bayer HealthCare Ascensia Breeze Ascensia BREEZE and Ascensia AUTODISCTM Unique 10-Test Disc User Manual

MULTIPLE SITE TESTING EVALUATION:

Forty-one persons with diabetes, in steady state for glucose,
performed self-capillary blood glucose assays using the
Ascensia ® B
REEZE
fingerstick was performed with the M
Lancing Device. Samples from the palm, forearm, thigh and
abdomen were obtained using the M
Lancing Device. Ascensia
sites were compared to those obtained from the finger. The
blood glucose range for the fingerstick measurements was
3.3 to 13.6 mmol/L, with an average of 7.5 mmol/L. The
hematocrit range was 38 to 53%, with an average of 45%.
A. Results from Palm (n = 36)
2 0
1 5
1 0
5
0
0
Ascensia
Finger Stick Result (mmol/L)
™ System and one test strip lot (Lot A). A
5 1 0 1 5
®
B ™
REEZE
B ™ results from the multiple
®
REEZE
B. Results from Forearm (n = 30)
y=x
2 0
Adjustable
®
ICROLET
® V
ICROLET ACULANCE
2 0
1 5
1 0
5
0
0 5
Ascensia
Finger Stick Result (mmol/L)
y=x
1 0 1 5 2 0
®
B ™
REEZE
37